SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: All Mtn Ski who wrote (1489)2/4/2002 3:07:47 PM
From: biostruggle  Read Replies (2) of 10345
 
2:32 (Dow Jones) Elan (ELN) getting brutalized for well documented reasons, but Merrill keeps long-term strong buy (cut its near-term rating.) Says company appears to be financially strong, with very positive operating cash flow and a very strong, liquid balance sheet. Its preliminary sum-of-the-parts estimate put a floor on the shares at $25-$30. Time to add a basement - shares off 49% at $15.30. (TG)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News